Medicis Pharmaceutical Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06+ | |
|---|---|---|---|
| Revenue | 517.8 | 464.7 | 349.2 |
| Cost of Goods Sold | 38.7 | 51.0 | 41.7 |
| Gross Profit | 479.0 | 413.7 | 307.5 |
| Gross Profit Margin | 92.5% | 89.0% | 88.0% |
| SG&A Expense | 279.8 | 247.9 | 206.8 |
| Depreciation & Amortization | 27.7 | 24.5 | 23.0 |
| Operating Income | 49.1 | 136.1 | (106.0) |
| Operating Margin | 9.5% | 29.3% | -- |
| Nonoperating Income | (15.5) | 0.0 | 0.0 |
| Nonoperating Expenses | 16.7 | -- | -- |
| Income Before Taxes | 42.4 | 126.1 | (116.6) |
| Income Taxes | 32.1 | 51.0 | (40.8) |
| Net Income After Taxes | 10.3 | 75.1 | (75.8) |
| Continuing Operations | 10.3 | 75.1 | (75.8) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 10.3 | 75.1 | (75.8) |
| Total Net Income | 10.3 | 75.1 | (75.8) |
| Net Profit Margin | 2.0% | 16.2% | -- |
| Diluted EPS from Total Net Income ($) | 0.18 | 1.14 | (1.39) |
| Dividends per Share | 0.16 | 0.12 | 0.12 |
© 2009 Morningstar, Inc. Financial Data provided by
